BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Globe Commercials Ltd. Share Price

NSE
BSE

BSE : 540266

Sector : Trading

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 2246.57 1623.64
Expenses N/A N/A
PBT 64.27 41.84
Operating profit 0.0 0.0
Net profit 47.56 30.54

Shareholding Pattern

Promoters (% Holding)

8.33%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

91.67%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Globe Commercials Ltd.

Founded 1985

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Adani Enterprises Ltd. 4,10,854.81 3,043.15 1,753.00 - 1,753.00
Aegis Logistics Ltd. 48,968.01 1,381.40 576.10 - 576.10
Premier Energies Ltd. 46,961.28 1,045.00 660.00 - 660.00
Aditya Infotech Ltd. 41,885.24 3,643.90 0.00 - 0.00
Redington Ltd. 27,213.57 351.00 191.31 - 191.31
Honasa Consumer Ltd. 14,992.22 465.95 248.40 - 248.40
Lloyds Enterprises Ltd. 12,439.87 80.00 40.69 - 40.69
MMTC Ltd. 9,565.50 64.06 50.10 - 50.10
SG Mart Ltd. 8,934.64 717.65 313.10 - 313.10
Cello World Ltd. 8,812.21 377.00 336.60 - 336.60
no-content No Records Found

Latest News

Jul
20
2026
EQUITY Posted on Jul 20th 2026

Globe Multi Ventures informs about confirmation certificate

Globe Multi Ventures has submitted the confirmation certificate dated 1st July, 2026 received from Skyline Financial Services, Registrar and share transfer Agent (RTA) of the company as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
6
2026
EQUITY Posted on Aug 6th 2026

Parshva Enterprises informs about outcome of board meeting

Parshva Enterprises has informed that pursuant to regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at their Meeting held today i.e. on Thursday, the August 06, 2026, have considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the Quarter ended 30th June, 2026. In respect of above, it has enclosed the following: 1) Un-Audited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2026. 2) Independent Auditor's Review Report issued by Bohara Shah & Co., Chartered Accountants., Statutory Auditors of the Company on the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter ended 3Qth June, 2026. The meeting of the Board of Directors commenced at 11:30 am and concluded at 12:20 pm.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
6
2026
EQUITY Posted on Aug 6th 2026

Callista Industries informs about SAST

Callista Industries has informed that it enclosed disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Manisha Vikaskumar Saraf.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
6
2026
COMPANY Posted on Aug 6th 2026

Biogen Pharmachem - Quaterly Results

A decrease of about -71.29% in the sales to Rs. 4.43 millions was observed for the quarter ended June 2026. The sales stood at Rs. 15.43 millions during the similar quarter previous year.A radical decline of -83.57% was reported in the net profit of the company for the quarter ended June 2026 to Rs. 2.21  millions from Rs. 13.45 millions.The company reported a degrowth in operating Profit to 2.21 millions from 13.45 millions.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 4.43 15.43 -71.29 4.43 15.43 -71.29 25.58 8.38 205.25
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 2.21 13.45 -83.57 2.21 13.45 -83.57 9.57 -2.93 -426.62
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.21 13.45 -83.57 2.21 13.45 -83.57 9.57 -2.93 -426.62
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 2.21 13.45 -83.57 2.21 13.45 -83.57 9.57 -2.93 -426.62
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.97 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2.21 13.45 -83.57 2.21 13.45 -83.57 8.60 -2.93 -393.52
Equity 1053.04 902.60 16.67 1053.04 902.60 16.67 902.60 652.60 38.31
PBIDTM(%) 49.89 87.17 -42.77 49.89 87.17 -42.77 37.41 -34.96 -207.00
Read More
Aug
6
2026
COMPANY Posted on Aug 6th 2026

Balaxi Pharma. - Quaterly Results

Net sales declined -6.73%  to  Rs. 155.84 million from Rs. 167.08 millions.The Net Loss for the quarter ended June 2026 is Rs. -12.53 millions as compared to Net Profit of Rs. 1.94 millions of corresponding quarter ended June 2025Operating profit Margin for the quarter ended June 2026 slipped to -0.78% as compared to 10.01% of corresponding quarter ended June 2025
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 155.84 167.08 -6.73 155.84 167.08 -6.73 808.51 609.88 32.57
Other Income 9.16 4.62 98.27 9.16 4.62 98.27 96.67 53.73 79.92
PBIDT -0.78 10.01 -107.79 -0.78 10.01 -107.79 104.31 78.02 33.70
Interest 4.46 6.31 -29.32 4.46 6.31 -29.32 26.96 20.58 31.00
PBDT -5.24 3.70 -241.62 -5.24 3.70 -241.62 77.35 57.44 34.66
Depreciation 5.92 1.13 423.89 5.92 1.13 423.89 7.02 4.56 53.95
PBT -11.16 2.57 -534.24 -11.16 2.57 -534.24 70.33 52.88 33.00
TAX 1.37 0.63 117.46 1.37 0.63 117.46 18.86 16.86 11.86
Deferred Tax 1.37 -0.18 -861.11 1.37 -0.18 -861.11 4.35 -0.96 -553.13
PAT -12.53 1.94 -745.88 -12.53 1.94 -745.88 51.47 36.02 42.89
Equity 110.42 110.42 0.00 110.42 110.42 0.00 110.42 110.42 0.00
PBIDTM(%) -0.50 5.99 -108.35 -0.50 5.99 -108.35 12.90 12.79 0.85
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Globe Commercials Ltd. ?

The current share price of Globe Commercials Ltd. is ₹20.00 as of 2026-08-06.

The market capitalisation of Globe Commercials Ltd. is ₹12.29 as of 2026-08-05.

The 1-year return of Globe Commercials Ltd. is -12.04% as of 2025-08-05.

The P/E ratio of Globe Commercials Ltd. is 2.29 as of 2026-08-06.

The 52-week high and low of Globe Commercials Ltd. are ₹36.30 and ₹12.40, respectively, as of 2026-08-06.

The dividend yield of Globe Commercials Ltd. is 0.0% as of2026-08-05.

You can buy Globe Commercials Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Globe Commercials Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore